Sumitomo Seika Chemicals (4008) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
20 Jul, 2026Executive summary
Net sales for FY2025 were ¥148.4 billion, up 0.5% year-over-year, with operating profit rising 35% to ¥14.5 billion and ordinary profit up 37.3% to ¥15.2 billion.
Profit attributable to owners increased 28.8% to ¥7.7 billion, despite extraordinary losses related to product mischarging and impairment in the Functional Materials segment.
Comprehensive income surged to ¥12,910 million from ¥2,880 million year-over-year.
Growth was driven by increased sales volumes in Super Absorbent Polymers (SAP) and Water-Soluble Polymers, and lower raw material and fuel costs.
Financial highlights
Net sales: ¥148.4 billion (+0.5% YoY); Operating profit: ¥14.5 billion (+35% YoY); Ordinary profit: ¥15.2 billion (+37.3% YoY).
Profit attributable to owners: ¥7.7 billion (+28.8% YoY).
ROE improved to 7.8% (+1.5pt YoY); ROIC rose to 8.1% (+1.1pt YoY); basic EPS ¥117.48.
Gross profit increased to ¥35,435 million from ¥30,681 million year-over-year.
Equity-to-asset ratio rose to 67.8%, and net assets per share reached ¥1,601.96.
Outlook and guidance
FY2026 financial forecast not finalized due to supply chain risks and uncertainty from Middle East tensions and the Strait of Hormuz blockade.
Most raw materials for Q1 secured; efforts ongoing to pass cost increases to customers.
SAP sales volume expected to rise ~4% in FY2026, driven by new Singapore facility.
Latest events from Sumitomo Seika Chemicals
- Ambitious 2045 vision and FY2030 targets set, with focus on sustainability and capital efficiency.4008
Investor presentation6 Aug 2026 - Strong sales and profit growth, but FY2027 outlook tempered by rising costs and global risks.4008
Q1 20276 Aug 2026 - Sales and operating profit rose, but profit fell on one-time losses; outlook cautious.4008
Q4 202520 Jul 2026 - Operating profit rose despite lower sales, with strong shareholder returns and capacity expansion.4008
Q2 202520 Jul 2026 - Operating profit up 19.9% despite 1.7% sales drop; profit hit by mischarging provision.4008
Q2 202620 Jul 2026 - Profits fell sharply on lower sales and business exits, but full-year profit is forecast to recover.4008
Q1 202520 Jul 2026 - Profits surged on strong polymer sales and FX gains, prompting an upward revision to forecasts.4008
Q3 202520 Jul 2026 - Profits fell sharply year-over-year, but full-year net profit is forecast to rise on one-time factors.4008
Q1 202620 Jul 2026 - Operating profit rose 18.7% despite lower sales, with full-year profit forecast revised upward.4008
Q3 202620 Jul 2026